Lv3
210 积分 2023-04-12 加入
Chronic graft-versus-host disease
1个月前
已完结
Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group
1个月前
已完结
Ruxolitinib for pediatric patients with treatment-naïve and steroid-refractory acute graft-versus-host disease: the REACH4 study
2个月前
已完结
Neoadjuvant immunochemoradiotherapy versus chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis of reconstructed individual patient data
1年前
已完结
皖公网安备34019202002308
